SLC7A11 and cancer: The SLC7A11-associated high-rate cysteine metabolism in tumor cells relies on the pentose phosphate pathway to generate substantial amounts of NAPDH, establishing a link to metabolic vulnerabilities that could guide therapies targeting cancers with high SLC7A11 expression [14].